Project Grant HT94252510164
Award Date
4/15/25
Completion Date
4/14/28
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $1,068,000.00 in funding to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research aimed at "Activating Gasdermin Pores to Induce Pyroptosis and Antitumor Immunity in Ovarian Cancers." The award period is from April 15, 2025 to April 14, 2028. As a premier pediatric medical research...
The U.S. Department of the Army Medical Command awarded a $577,383 Project Grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a start date of September 1, 2024 and an ultimate completion date of August 31, 2027, will support the hospital's research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS." As...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $617,367.00 to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research, which commenced on Sep 1, 2024 and is scheduled for completion by Aug 31, 2027, aims to explore...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $177,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a project to develop a nanoparticle-based CRISPR screen to identify genetic regulators of chemoresistance. The screen will be used to investigate medical solutions for the battlefield by transforming health care for service members and the public...
This $3,062,579 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports an integrated research effort by The Children's Hospital Corporation (doing business as Boston Children's Hospital) to identify biopsychosocial aspects of pain in fibrous dysplasia/McCune-Albright syndrome. The research aims to advance understanding and treatment of this rare genetic disorder, with a focus on transforming...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...